These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 15233824

  • 21. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.
    Alberú J, Pascoe MD, Campistol JM, Schena FP, Rial Mdel C, Polinsky M, Neylan JF, Korth-Bradley J, Goldberg-Alberts R, Maller ES, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2011 Aug 15; 92(3):303-10. PubMed ID: 21792049
    [Abstract] [Full Text] [Related]

  • 22. Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR).
    Delgado JF, Crespo MG, Manito N, Camprecios M, Rábago G, Lage E, Arizón JM, Roig E.
    Transplant Proc; 2009 Nov 15; 41(9):3835-7. PubMed ID: 19917397
    [Abstract] [Full Text] [Related]

  • 23. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
    Benavides CA, Pollard VB, Mauiyyedi S, Podder H, Knight R, Kahan BD.
    Transplantation; 2007 Jul 15; 84(1):83-8. PubMed ID: 17627242
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W, Ficheux M, Debruyne D, Rognant N, Lobbedez T, Allard C, Coquerel A, Ryckelynck JP, Hurault de Ligny B.
    Transplant Proc; 2005 Mar 15; 37(2):864-6. PubMed ID: 15848558
    [Abstract] [Full Text] [Related]

  • 25. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
    Lisik W, Schoenberg L, Lasky RE, Kahan BD.
    Transplant Proc; 2007 Dec 15; 39(10):3086-92. PubMed ID: 18089328
    [Abstract] [Full Text] [Related]

  • 26. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
    Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL.
    Clin Transplant; 1994 Aug 15; 8(4):388-95. PubMed ID: 7949545
    [Abstract] [Full Text] [Related]

  • 27. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 28. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy.
    Yakupoglu YK, Buell JF, Woodle S, Kahan BD.
    Transplant Proc; 2006 Mar 15; 38(2):358-61. PubMed ID: 16549120
    [Abstract] [Full Text] [Related]

  • 29. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Dec 15; 38(10):3473-5. PubMed ID: 17175308
    [Abstract] [Full Text] [Related]

  • 30. Conversion to sirolimus in pediatric renal transplantation recipients.
    Garcia CD, Bittencourt VB, Alves AB, Garcia VD, Tumelero A, Antonello JS, Malheiros D.
    Transplant Proc; 2006 Dec 15; 38(6):1901-3. PubMed ID: 16908317
    [Abstract] [Full Text] [Related]

  • 31. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 32. Sirolimus in chronic allograft nephropathy in pediatric recipients.
    Ibáñez JP, Monteverde ML, Diaz MA, Goldberg J, Turconi AF.
    Pediatr Transplant; 2007 Nov 15; 11(7):777-80. PubMed ID: 17910656
    [Abstract] [Full Text] [Related]

  • 33. Characteristics of neoplasm occurrence and the therapeutic effect of sirolimus in South Chinese kidney transplant recipients.
    Wang CX, Liu LS, Chen LZ, Chen SY, Wu PG, Fei JG, Qiu J, Deng SX, Zheng KL, Ji YL, Zhu LY, Shen QR, He XS.
    Transplant Proc; 2006 Dec 15; 38(10):3536-9. PubMed ID: 17175325
    [Abstract] [Full Text] [Related]

  • 34. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
    Sommerer C, Hartschuh W, Enk A, Meuer S, Zeier M, Giese T.
    Clin Transplant; 2008 Dec 15; 22(5):549-54. PubMed ID: 18394001
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients.
    Knight RJ, Villa M, Laskey R, Benavides C, Schoenberg L, Welsh M, Kerman RH, Podder H, Van Buren CT, Katz SM, Kahan BD.
    Clin Transplant; 2007 Dec 15; 21(4):460-5. PubMed ID: 17645704
    [Abstract] [Full Text] [Related]

  • 36. Conversion to sirolimus in renal transplant patients with tumors.
    Sánchez-Fructuoso A, Conesa J, Perez Flores I, Ridao N, Calvo N, Prats D, Rodríguez A, Barrientos A.
    Transplant Proc; 2006 Oct 15; 38(8):2451-2. PubMed ID: 17097964
    [Abstract] [Full Text] [Related]

  • 37. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
    Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2005 Nov 15; 80(9):1204-11. PubMed ID: 16314787
    [Abstract] [Full Text] [Related]

  • 38. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.
    Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J.
    Transplantation; 1999 Nov 27; 68(10):1526-32. PubMed ID: 10589950
    [Abstract] [Full Text] [Related]

  • 39. Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.
    Lasmar EP, Coelho LG, Lasmar MF, Lasmar LF, Lima PV, Nogueira AF.
    Transplant Proc; 2009 Apr 27; 41(3):959-61. PubMed ID: 19376398
    [Abstract] [Full Text] [Related]

  • 40. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ, Tian YC, Chen YC, Lai BC, Fang JT, Yang CW, Wu MS.
    Ren Fail; 2008 Apr 27; 30(3):303-6. PubMed ID: 18350450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.